How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: Correlation with ultrasound

Liver International

Volumn 34, Issue 6, 2014, Pages

  Carvalhana, Sofia ^a   Leitão, Jorge ^b   Alves, Ana C ^c   Bourbon, Mafalda ^c   Cortez Pinto, Helena ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Controlled attenuation parameter; Fatty liver; Fibroscan; General population; Hepatic steatosis; Liver stiffness

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; ALCOHOL CONSUMPTION; ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED ATTENUATION PARAMETER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOGRAPHY; ELASTOGRAPH; FATTY LIVER; FATTY LIVER INDEX; FEMALE; HAMAGUCHI US SCORING; HEPATOBILIARY PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RIGIDITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND SCANNER; WAIST CIRCUMFERENCE; AGED; AREA UNDER THE CURVE; BLOOD; ELASTICITY; ELASTOGRAPHY; EVALUATION STUDY; LIVER; MASS SCREENING; METABOLISM; MIDDLE AGED; PATHOLOGY; PORTUGAL; PREVALENCE; PROCEDURES; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MASS SCREENING; MIDDLE AGED; PORTUGAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84902550192     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12305     Document Type: Article

References (16)

1. Lazo M, Clark J. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-50.
2. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-7.
3. Farrell G, Larter C. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-112.
4. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009; 49: 306-17.
5. Sung KC, Wild SH, Kwag HJ, Byrne CD. Fatty liver, insuline resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10, 153 people. Diabetes Care 2012; 35: 2359-64.
6. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372-84.
7. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-906.
8. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-15.
9. Dasarathy S, Dasarathy J, Khiyami A, et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-7.
10. Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled Attenuation Parameter (CAP): a Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes. Ultrasound Med Biol 2010; 36: 1825-35.
11. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
12. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31.
13. Kumar M, Rastogi A, Singh T, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does aetiology affect performance. J Gastroenterol Hepatol 2013; 28: 1194-201.
14. de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012; 32: 911-8.
15. Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51: 433-45.
16. Ballestri S, Lonardo A, Romagnoli D, et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int 2012; 32: 1242-52.